Comparison of Moxalactam (LY127935) and cefotaxime against anaerobic bacteria

J. H. Jorgensen, S. A. Crawford, G. A. Alexander

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


The in vitro activities of moxalactam (LY127935 [6059S]) and cefotaxime were compared with those of cefoxitin, cefamandole, cefuroxime, carbenicillin, and penicillin by agar dilution susceptibility testing of a variety of anaerobic bacteria. Moxalactam proved to be the most active agent tested against Bacteroides fragilis and other species of the B. fragilis group. Moxalactam and cefotaxime showed activity similar to the other drugs against the remaining species of Bacteroides, Fusobacterium, Actinomyces, Propionibacterium, and Veillonella. Penicillin was the most effective drug tested against most species of Clostridium, the anaerobic gram-positive cocci, and Eubacterium lentum.

Original languageEnglish (US)
Pages (from-to)901-904
Number of pages4
JournalAntimicrobial agents and chemotherapy
Issue number5
StatePublished - 1980
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases


Dive into the research topics of 'Comparison of Moxalactam (LY127935) and cefotaxime against anaerobic bacteria'. Together they form a unique fingerprint.

Cite this